Discover 1,272 paid clinical trials in Mesa, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,272
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
for
Obesity, Overweight, Diabetes Mellitus, Type 2
Location: Gilbert AZ, Phoenix AZ, Tucson AZ, Las Vegas NV,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07215559
Phase2, Recruiting
Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus
for
Chronic Kidney Disease (Stages 4 and 5), Kidney Disease,
Location: Scottsdale AZ, Phoenix AZ
Sponsor: Well Cell Global
Sex: All
Age: 18+
Code: NCT07187479
Recruiting
Study of MAR002 in Healthy Men
for
Acromegaly
Location: Tempe AZ
Sponsor: Marea Therapeutics
Sex: Male
Age: 18 - 40
Code: NCT07195175
Phase1, Recruiting
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
for
Atopic Dermatitis
Location: Gilbert AZ, Phoenix AZ, Las Vegas NV, San Diego CA,
Sponsor: Sanofi
Sex: All
Age: 12+
Code: NCT07290803
Recruiting
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
for
Cardiovascular Disease
Location: Tempe AZ, Gilbert AZ, Scottsdale AZ, Phoenix AZ,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07000357
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
for
Heart Failure
Location: Tempe AZ, Gilbert AZ, Glendale AZ, Tucson AZ,
Sponsor: AstraZeneca
Sex: All
Age: 40+
Code: NCT06677060
Phase3, Recruiting
A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
for
Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia
Location: Chandler AZ, Scottsdale AZ, Henderson NV, El Paso TX,
Sponsor: Centessa Pharmaceuticals (UK) Limited
Sex: All
Age: 18 - 65
Code: NCT06752668
Phase2, Recruiting
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
for
Uterine Fibroids, Endometriosis
Location: Chandler AZ, Phoenix AZ, Mesa AZ, Peoria AZ, Tucson AZ,
Sponsor: Sumitomo Pharma Switzerland GmbH
Sex: Female
Age: 18 - 50
Code: NCT05862272
Phase3, Recruiting
A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia
for
Dystonia
Location: Scottsdale AZ, Sun City AZ, Albuquerque NM, Irvine CA,
Sponsor: Vima Therapeutics
Sex: All
Age: 18 - 65
Code: NCT07304089
Phase2, Recruiting
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
for
Ocular Myasthenia Gravis
Location: Scottsdale AZ, O'Fallon IL, Greenfield WI, Columbus OH,
Sponsor: UCB Biopharma SRL
Sex: All
Age: 18+
Code: NCT07463521
Phase3, Recruiting
OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity
for
Vision Loss Night, Vision Disorders
Location: Chandler AZ, Scottsdale AZ, Phoenix AZ, San Diego CA,
Sponsor: Ocuphire Pharma, Inc.
Sex: All
Age: 18+
Code: NCT07140783
Phase3, Recruiting
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
for
Alzheimer Disease, Agitation
Location: Scottsdale AZ, Las Vegas NV, Bountiful UT,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 55 - 70+
Code: NCT06937229
Phase3, Recruiting
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
for
Alzheimer Disease
Location: Scottsdale AZ, Las Vegas NV, El Paso TX, Pomona CA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 55 - 70+
Code: NCT07011732
Phase3, Recruiting
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
for
Crohn Disease
Location: Chandler AZ, Scottsdale AZ, Litchfield Park AZ,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07196722
Phase2, Phase3, Recruiting
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
for
Colitis, Ulcerative
Location: Chandler AZ, Scottsdale AZ, Litchfield Park AZ,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 12+
Code: NCT07196748
Phase3, Recruiting
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
for
Colitis, Ulcerative
Location: Mesa AZ, La Jolla CA, Los Alamitos CA, Littleton CO,
Sponsor: Pfizer
Sex: All
Age: 18 - 64
Code: NCT06398626
Recruiting
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
for
Generalized Myasthenia Gravis
Location: Scottsdale AZ, Phoenix AZ, Tucson AZ, Rancho Mirage CA,
Sponsor: Immunovant Sciences GmbH
Sex: All
Age: 18 - 70+
Code: NCT07039916
Phase3, Recruiting
A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
for
Non-muscle-invasive Bladder Cancer
Location: Mesa AZ, Murrieta CA, Downey CA, Bakersfield CA,
Sponsor: SURGE Therapeutics
Sex: All
Age: 18+
Code: NCT05710848
Phase1, Phase2, Recruiting
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
for
Systemic Lupus Erythematosus
Location: Chandler AZ, Gilbert AZ, Scottsdale AZ, Phoenix AZ,
Sponsor: UCB Biopharma SRL
Sex: All
Age: 16+
Code: NCT06617325
Phase3, Recruiting
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
for
Obesity, Overweight, Chronic Weight Management,
Location: Chandler AZ, San Diego CA, La Jolla CA,
Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics